A Compartive Multicenter Study of Neoadjuvant Docetaxel/Cisplatin Followed by Concurrent Cisplatin with Radiotherapy using Intensity-Modulated Radition Therapy (IMRT) with or without Bevacizumab for Locally Advanced Nasopharyngeal Cancer

drug protocol number
Version 1.3 date 6 may 2012
drug sponsor
King Fahad Medical City
drug study
Docetaxel/Cisplatin and Bevacizumab
drug trial site
KFMC
drug status
Completed
drug phase